Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan;19(1):2.
doi: 10.1007/s11912-017-0561-1.

Endoluminal and Interstitial Brachytherapy for the Treatment of Gastrointestinal Malignancies: a Systematic Review

Affiliations

Endoluminal and Interstitial Brachytherapy for the Treatment of Gastrointestinal Malignancies: a Systematic Review

Sujana Gottumukkala et al. Curr Oncol Rep. 2017 Jan.

Abstract

Radiation therapy is an integral component in the multimodality management of many gastrointestinal (GI) cancers at all stages of clinical presentation. With recent advances in technology and radiation delivery, external beam radiation therapy (EBRT) can be delivered with reduced toxicity. However, despite these advances, EBRT doses are still limited by the presence of radiosensitive serial structures near clinical targets in the GI tract. Relative to EBRT techniques, brachytherapy techniques have a lower integral dose and more rapid fall-off, allowing for high-dose delivery with little normal tissue exposure. Given the unique characteristics of brachytherapy, it is an attractive strategy to treat GI malignancies. This review addresses the application of both high-dose rate brachytherapy (HDRBT) and low-dose rate brachytherapy (LDRBT) to multiple GI malignancies for both definitive and palliative management.

Keywords: Biliary brachytherapy; Brachytherapy; Endoesophageal brachytherapy; Endoluminal brachytherapy; Endorectal brachytherapy; Gastrointestinal malignancy; High-dose rate brachytherapy; Interstitial brachytherapy; Low-dose rate brachytherapy; Palliative care.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Oncol. 2012 Jun 1;30(16):1926-33 - PubMed
    1. Eur J Cancer. 2016 May;59:142-151 - PubMed
    1. Cancer J Sci Am. 1996 Jul-Aug;2(4):205-11 - PubMed
    1. Ann Surg. 2005 Aug;242(2):158-71 - PubMed
    1. J Clin Oncol. 2009 Nov 1;27(31):5124-30 - PubMed

Publication types

MeSH terms

LinkOut - more resources